Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study

Introduction A substantial number of heart failure patients undergoing implantation of implantable cardioverter defibrillators (ICDs) fail to receive beta-blockers, or receive them at a suboptimal dose. Remote monitoring (RM) is becoming the standard means of following up recipients of ICDs. However...

Full description

Saved in:
Bibliographic Details
Published in:Journal of telemedicine and telecare 2016-10, Vol.22 (7), p.383-390
Main Authors: D’Onofrio, Antonio, Stabile, Giuseppe, Capucci, Alessandro, Amellone, Claudia, De Simone, Antonio, Leoni, Loira, Morani, Giovanni, Bianchi, Valter, Campari, Monica, Valsecchi, Sergio, Buja, Gianfranco
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - administration & dosage
Adrenergic beta-Antagonists - therapeutic use
Aged
Beta blockers
Bisoprolol - administration & dosage
Bisoprolol - therapeutic use
Carbazoles - administration & dosage
Carbazoles - therapeutic use
Defibrillators
Defibrillators, Implantable
Female
Humans
Impact analysis
Male
Medication Adherence
Monitoring, Ambulatory - methods
Patients
Propanolamines - administration & dosage
Propanolamines - therapeutic use
Prospective Studies
Receiving
Remote monitoring
Telecare
Telemedicine
Transplants & implants
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction A substantial number of heart failure patients undergoing implantation of implantable cardioverter defibrillators (ICDs) fail to receive beta-blockers, or receive them at a suboptimal dose. Remote monitoring (RM) is becoming the standard means of following up recipients of ICDs. However, the impact of this shift toward remote ICD follow-up on the quality of drug therapy management in current clinical practice is unknown. The present analysis was aimed at investigating the impact of RM on the dose of beta-blockers achieved, and its association with clinical outcome at 12 months. Methods Altogether 987 consecutive patients were enrolled and followed up for at least 12 months in 25 Italian centres. RM was adopted by 499 patients. Results The number of patients receiving beta-blockers at any dose decreased after 12 months (from 403 (81%) to 370 (74%) for the remote arm and from 389 (80%) to 342 (70%) for the standard arm, both p 
ISSN:1357-633X
1758-1109
DOI:10.1177/1357633X15613701